Literature DB >> 22752791

Backbone ¹H, ¹³C, and ¹⁵N chemical shift assignment for HIV-1 protease subtypes and multi-drug resistant variant MDR 769.

Xi Huang1, Ian Mitchelle S de Vera, Angelo M Veloro, James R Rocca, Carlos Simmerling, Ben M Dunn, Gail E Fanucci.   

Abstract

HIV-1 protease (HIV-1PR) is an essential drug target in the treatment of patients infected with HIV-1. Mutations are found to arise in over 38 of 99 amino acid sites in this protein in response to drug therapy or natural selection, where many are found combinations that alter enzyme kinetics or inhibitor susceptibility without a clear structural mechanism. In efforts to understand how these mutations alter the flexibility and dynamics of HIV-1PR, we report the backbone (1)H, (13)C, and (15)N chemical shift assignments for subtypes C, circulating recombinant form CRF01_AE and a multi-drug resistant variant MDR 769. These assignments are essential for future work aimed at characterizing backbone dynamics, exchange dynamics and dynamics of protein/substrate or protein/inhibitor interactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752791      PMCID: PMC3518686          DOI: 10.1007/s12104-012-9409-7

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  12 in total

1.  Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.

Authors:  Adrian Velazquez-Campoy; Sonia Vega; Ernesto Freire
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

2.  Structural characterization of B and non-B subtypes of HIV-protease: insights into the natural susceptibility to drug resistance development.

Authors:  Mario Sanches; Sandra Krauchenco; Nadia H Martins; Alla Gustchina; Alexander Wlodawer; Igor Polikarpov
Journal:  J Mol Biol       Date:  2007-03-24       Impact factor: 5.469

3.  Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.

Authors:  Moses Prabu-Jeyabalan; Nancy M King; Ellen A Nalivaika; Gabrielle Heilek-Snyder; Nick Cammack; Celia A Schiffer
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations.

Authors:  Darón I Freedberg; Rieko Ishima; Jaison Jacob; Yun-Xing Wang; Irina Kustanovich; John M Louis; Dennis A Torchia
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

6.  An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.

Authors:  P Ashorn; T J McQuade; S Thaisrivongs; A G Tomasselli; W G Tarpley; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Drug pressure selected mutations in HIV-1 protease alter flap conformations.

Authors:  Luis Galiano; Fangyu Ding; Angelo M Veloro; Mandy E Blackburn; Carlos Simmerling; Gail E Fanucci
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

8.  Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.

Authors:  Jamie L Kear; Mandy E Blackburn; Angelo M Veloro; Ben M Dunn; Gail E Fanucci
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

9.  The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

Authors:  A M Mildner; D J Rothrock; J W Leone; C A Bannow; J M Lull; I M Reardon; J L Sarcich; W J Howe; C S Tomich; C W Smith
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

10.  HIV-1 Protease: Structural Perspectives on Drug Resistance.

Authors:  Irene T Weber; Johnson Agniswamy
Journal:  Viruses       Date:  2009-12-03       Impact factor: 5.048

View more
  4 in total

1.  Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Authors:  Thomas M Casey; Gail E Fanucci
Journal:  Methods Enzymol       Date:  2015-09-01       Impact factor: 1.600

2.  Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational sampling.

Authors:  Jeffrey D Carter; Estrella G Gonzales; Xi Huang; Adam N Smith; Ian Mitchelle S de Vera; Peter W D'Amore; James R Rocca; Maureen M Goodenow; Ben M Dunn; Gail E Fanucci
Journal:  FEBS Lett       Date:  2014-06-28       Impact factor: 4.124

3.  The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics.

Authors:  Xi Huang; Manuel D Britto; Jamie L Kear-Scott; Christopher D Boone; James R Rocca; Carlos Simmerling; Robert Mckenna; Michael Bieri; Paul R Gooley; Ben M Dunn; Gail E Fanucci
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

4.  Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.

Authors:  Ravikiran S Yedidi; Joseck M Muhuhi; Zhigang Liu; Krisztina Z Bencze; Kyriacos Koupparis; Carrie E O'Connor; Iulia A Kovari; Mark R Spaller; Ladislau C Kovari
Journal:  Biochem Biophys Res Commun       Date:  2013-08-03       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.